Viatris (VTRS) Other Accumulated Expenses (2019 - 2026)
Viatris (VTRS) recorded quarterly Other Accumulated Expenses of $3.1 billion in Q1 2026, down 4.66% quarter-over-quarter from $3.3 billion in Q4 2025, and down 13.77% on a YoY basis from $3.6 billion in Q1 2025.
Viatris (VTRS) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
Viatris' Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $3.1 billion for Q1 2026.
- In Q1 2026, Other Accumulated Expenses fell 13.77% year-over-year to $3.1 billion; the TTM figure through Mar 2026 stood at $3.1 billion (down 13.77% YoY), while the FY2025 annual figure was $3.3 billion, down 11.86% from the prior year.
- Other Accumulated Expenses was $3.1 billion for Q1 2026 at Viatris, down from $3.3 billion in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $4.4 billion in Q1 2022 to a low of $3.0 billion in Q2 2023.
- Historically, Other Accumulated Expenses has averaged $3.5 billion across 5 years, with a median of $3.4 billion in 2022.
- The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses slipped 27.87% in 2023, then rose 16.27% in 2024.
- A 5-year view of Other Accumulated Expenses shows it stood at $3.4 billion in 2022, then decreased by 1.37% to $3.4 billion in 2023, then advanced by 9.75% to $3.7 billion in 2024, then slipped by 11.86% to $3.3 billion in 2025, then decreased by 4.66% to $3.1 billion in 2026.
- The last three Other Accumulated Expenses figures came in at $3.1 billion (Q1 2026), $3.3 billion (Q4 2025), and $3.6 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Viatris | - | - | 1.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.13 Bn |
| Dec 31, 2025 | 3.28 Bn |
| Sep 30, 2025 | 3.62 Bn |
| Jun 30, 2025 | 3.67 Bn |
| Mar 31, 2025 | 3.63 Bn |
| Dec 31, 2024 | 3.72 Bn |
| Sep 30, 2024 | 3.86 Bn |
| Jun 30, 2024 | 3.23 Bn |
| Mar 31, 2024 | 3.28 Bn |
| Dec 31, 2023 | 3.39 Bn |
| Sep 30, 2023 | 3.32 Bn |
| Jun 30, 2023 | 3.05 Bn |
| Mar 31, 2023 | 3.19 Bn |
| Dec 31, 2022 | 3.44 Bn |
| Sep 30, 2022 | 3.50 Bn |
| Jun 30, 2022 | 3.81 Bn |
| Mar 31, 2022 | 4.43 Bn |
| Dec 31, 2021 | 4.62 Bn |
| Sep 30, 2021 | 4.63 Bn |
| Jun 30, 2021 | 4.21 Bn |